An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.
Public ClinicalTrials.gov record NCT00407095. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT00407095
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Solvay Pharmaceuticals
- Industry
- Enrollment
- 140 participants
Conditions and interventions
Conditions
Interventions
- Pardoprunox Drug
Drug
Eligibility (public fields only)
- Age range
- 30 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2007
- Primary completion
- Apr 30, 2009
- Completion
- Apr 30, 2009
- Last update posted
- Sep 12, 2010
2007 – 2009
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| S308.3.007 Site # 220 | La Jolla | California | — | — |
| S308.3.007 Site # 211 | San Francisco | California | — | — |
| S308.3.007 Site # 214 | Fort Lauderdale | Florida | — | — |
| S308.3.007 Site # 218 | Gainsville | Florida | — | — |
| S308.3.007 Site # 213 | Tampa | Florida | — | — |
| S308.3.007 Site # 219 | Augusta | Georgia | — | — |
| S308.3.007 Site # 221 | Chicago | Illinois | — | — |
| S308.3.007 Site # 216 | Kansas City | Kansas | — | — |
| S308.3.007 Site # 224 | Lexington | Kentucky | — | — |
| S308.3.007 Site # 212 | East Lansing | Michigan | — | — |
| S308.3.007 Site # 217 | St Louis | Missouri | — | — |
| S308.3.007 Site # 222 | Durham | North Carolina | — | — |
| S308.3.007 Site # 210 | Tledo | Ohio | — | — |
| S308.3.007 Site # 215 | Houston | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 73 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00407095, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 12, 2010 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00407095 live on ClinicalTrials.gov.